Gossamer Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gossamer Bio and other ETFs, options, and stocks.About GOSS
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions.
GOSS Key Statistics
Stock Snapshot
With a market cap of 66.21M, Gossamer Bio(GOSS) trades at $10.84. The stock has a price-to-earnings ratio of -0.20.
On 2026-09-24, Gossamer Bio(GOSS) stock traded between a low of $10.75 and a high of $11.68. Shares are currently priced at $10.84, which is +0.8% above the low and -7.2% below the high.
The Gossamer Bio(GOSS)'s current trading volume is 160.83K, compared to an average daily volume of 316.66K.
In the last year, Gossamer Bio(GOSS) shares hit a 52-week high of $309.60 and a 52-week low of $9.10.
In the last year, Gossamer Bio(GOSS) shares hit a 52-week high of $309.60 and a 52-week low of $9.10.
GOSS News
...
Gossamer Bio ( (GOSS) ) has shared an update. On September 23, 2026, Gossamer Bio, Inc. reported that it submitted its first New Drug Application to the U.S. F...
Gossamer Bio (GOSS) announced that it submitted a New Drug Application to the U.S. Food and Drug Administration in September 2026 for seralutinib for the treatm...
Analyst ratings
43%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.